Latest filing published 17 Jun 2026 for Acumen Pharmaceuticals, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Derrell Porter is a declared insider of Acumen Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). We count 7 filings; the first trade dates from 4 June 2025 and the latest from 17 June 2026.
Every open-market trade on record is a sale: 3 sales. The amount is not disclosed for 3 filings. Besides market trades, the filings include 2 share grants and 2 option exercises. In 2026 alone, the filings show no purchases and 3 sales.
On 17 June 2026 came the latest disclosure, an option exercise in Acumen Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations